Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidehisa Saeki

Showing results (1-10 of 440) with videos related to

Pageof 44
Sort By:
Arerugi = [Allergy]|December 21, 2022
[THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2021]Hidehisa Saeki
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 13, 2002
[Atopic dermatitis]Hidehisa Saeki
Arerugi = [Allergy]|June 14, 2023
[Erratum : GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2021 [Japanese Journal of Allergology Vol.70 (2021) No.10 p.1257-1342]]Hidehisa Saeki
Arerugi = [Allergy]|March 12, 2010
[The brief commentary on guidelines for the management of atopic dermatitis 2009--the point of drug treatment]Hidehisa Saeki
Arerugi = [Allergy]|December 14, 2018
[THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2018]Hidehisa Saeki
Arerugi = [Allergy]|December 16, 2021
[GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2021]Hidehisa Saeki
Arerugi = [Allergy]|March 11, 2014
[Brief commentary on guidelines for the management of atopic dermatitis 2012 -the point of drug treatment]Hidehisa Saeki
Arerugi = [Allergy]|December 15, 2024
[Erratum : GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2024 [Japanese Journal of Allergology Vol.73 (2024) No.9 p.1025-1125]]Hidehisa Saeki
Arerugi = [Allergy]|January 5, 2016
[THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2015--the point of drug treatment]Hidehisa Saeki
Arerugi = [Allergy]|March 28, 2013
[Biomarker of atopic dermatits -focusing on serum TARC/CCL17 level as severity marker-]Hidehisa Saeki
Pageof 44

Showing results (1-10 of 440) with videos related to

Sort By:
Pageof 44
Arerugi = [Allergy]|December 21, 2022
[THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2021]Hidehisa Saeki
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 13, 2002
[Atopic dermatitis]Hidehisa Saeki
Arerugi = [Allergy]|June 14, 2023
[Erratum : GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2021 [Japanese Journal of Allergology Vol.70 (2021) No.10 p.1257-1342]]Hidehisa Saeki
Arerugi = [Allergy]|March 12, 2010
[The brief commentary on guidelines for the management of atopic dermatitis 2009--the point of drug treatment]Hidehisa Saeki
Arerugi = [Allergy]|December 14, 2018
[THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2018]Hidehisa Saeki
Arerugi = [Allergy]|December 16, 2021
[GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2021]Hidehisa Saeki
Arerugi = [Allergy]|March 11, 2014
[Brief commentary on guidelines for the management of atopic dermatitis 2012 -the point of drug treatment]Hidehisa Saeki
Arerugi = [Allergy]|December 15, 2024
[Erratum : GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2024 [Japanese Journal of Allergology Vol.73 (2024) No.9 p.1025-1125]]Hidehisa Saeki
Arerugi = [Allergy]|January 5, 2016
[THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2015--the point of drug treatment]Hidehisa Saeki
Arerugi = [Allergy]|March 28, 2013
[Biomarker of atopic dermatits -focusing on serum TARC/CCL17 level as severity marker-]Hidehisa Saeki
Pageof 44